Indications for Dose Adjustment of Thyroid Hormones in Older Patients.

Authors

Joerg Bojunga, Viktoria Florentine Koehler, Michael Drey, Cornelia Jaursch-Hancke, Michael Denkinger

Published in

Deutsches Arzteblatt international. Volume 123. Issue 23. Nov 13, 2026. Epub Nov 13, 2026.

Abstract

Thyroid dysfunction is common in older people (persons aged 65 and above). A meta-analysis of data from European countries revealed a 4.1% prevalence of undiagnosed subclinical hypothyroidism. It was found in a primary care study from the United Kingdom that approximately 10 percent of people over age 70 were under treatment for hypothyroidism.
This narrative review is based on findings in relevant publications retrieved by a PubMed search and on the guidelines of the European Thyroid Association and the American Thyroid Association.
Overtreatment with levothyroxine increases the risk of cardiovascular, cognitive, and skeletal complications (hazard ratio 1.37-2.02). Randomized controlled trials have not shown that treatment with levothyroxine (T4) improves presumed symptoms of hypothyroidism, body weight, or fatigue. In patients who are now taking levothyroxine, lowering the dose or stopping the drug should be considered; in older patients, the target range for thyroid-stimulating hormone (TSH) should be 4-10 mU/L. After levothyroxine is stopped, some patients remain euthyroid; in the absence of an indication, gradual tapering may be considered. Levothyroxine should not be given over the long term to patients with thyroid nodules. Subclinical hyperthyroidism in older people is associated with clinically relevant risks, particularly atrial fibrillation and bone fractures, and should therefore be treated. Its most common cause, however, is levothyroxine treatment that is either not indicated or improperly dosed.
While overt hypothyroidism and hyperthyroidism must be treated at any age, the need to treat subclinical hypothyroidism should be individually assessed; subclinical hyperthyroidism, by contrast, generally warrants treatment given its associated risks. In view of the risks of inadequately treated hyperthyroidism and excessively dosed levothyroxine, physicians should regularly review the indication for treatment, the dosage, and the possibility of lowering the dose or discontinuing the drug.

PMID:
42768899
Bibliographic data and abstract were imported from PubMed on 22 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.